ArticleJournal of hepatocellular carcinoma2024

Efficacy and Safety Analysis of Transarterial Chemoembolization Plus Donafenib With or Without Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Prospective, Single-Arm, Single-Center, Phase II Clinical Study.

Jinpeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.